filmov
tv
The evolution of oral anticoagulants

Показать описание
Blood clots can form where they aren't needed, and cause serious medical problems. This animation produced by Nature Reviews Cardiology and Nature Reviews Drug Discovery explores progress in the development of oral anticoagulants that target components of the blood coagulation cascade to inhibit blood clotting in high-risk patients, as well as recent advances with antidotes to reverse the effects of oral anticoagulants when necessary.
The evolution of oral anticoagulants
Oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism
Keynote Lecture: Novel Oral Anticoagulants and GI Cancer Patients
NOACs should replace warfarin in all patients with atrial fibrillation - Pro - J. Camm
NOACs fact and fiction
Dr. William W. Wilson Talk 1 on Novel Oral Anticoagulants
Information for Patients about their Oral Anticoagulant
Reversal of newer anticoagulants – When and how
Learning the Latest in Anticoagulants
Dr. William W. Wilson Talk 3 on Novel Oral Anticoagulants
How Do Drugs Work: Warfarin & Novel Oral Anticoagulants
Direct Oral Anticoagulants Presentation - Philip S. Wells, MD
Marco Proietti, EHRA 2018 – the Risk of Oral Anticoagulants and NSAIDs
`New Oral Anticoagulants
Dr. William W. Wilson Talk 2 on Novel Oral Anticoagulants
Managing Bleeding Events in Patients Receiving Direct Oral Anticoagulants
2017 Spring Symposium: Oral Anticoagulants
Blood, rats and anticoagulants: The story of warfarin
NOAC vs Warfarin, Current Status of Venous Anticoagulation (Baltazar MD; Petkova MD) March 24, 2021
Dr. Christian Ruff - Novel Oral Anticoagulants
Performance of oral anticoagulants in high risk patient populations with atrial fibrillation
New Oral Anticoagulants
Risk factors for oral anticoagulant-associated ICH
Oral Anticoagulants || Warfarin || Rivaroxaban || Apixiban || Dabigatran
Комментарии